!“#$%&‘()*+,–./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|} !“#$%&‘()*+,–./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}
Greg Abel might just be a little looser with the purse strings than Warren Buffett. Abel, who succeeded Buffett as Berkshire Hathaway’s CEO at the turn of this year, oversaw a drop in the conglomerate’s mountain of cash and Treasury bills from $380 billion at the end of March to $365 billion at the end…
B.Riley cuts Nuscale Power stock price target on valuation reset
Shares of Sweetgreen (SG +13.83%) rallied on Friday after health officials identified the source of a worrisome illness that has spread rapidly across the U.S. Image source: Getty Images. A welcome relief Prior to today, Sweetgreen’s stock had lost about a quarter of its value due to concerns regarding the cyclospora parasite that has sickened…
Luxury real estate has entered a new amenities arms race—and this time, it has very little to do with sprawling spas, cold plunges or tricked-out fitness centers. Instead, some of the biggest names in the culinary world are teaming up with high-end residential developers, with Michelin-starred chefs and celebrity restaurateurs creating private dining experiences exclusively…
In the latest big-ticket deal in the pharmaceutical industry, Vertex Pharmaceuticals (VRTX 1.31%) and Crinetics Pharmaceuticals (CRNX +98.74%) announced in a joint press release that Vertex is acquiring Crinetics. This won’t come cheap, to put it mildly; it’s a premium-priced deal that will cost billions of dollars. Here’s a look at whether that’s likely to…
This article was written by Follow I’m an independent equity trader and licensed financial advisor focused on uncovering high-upside opportunities in overlooked sectors especially focusing on small-caps, energy, commodities, and special situations. My investment strategy is based on growth. I look for fundamental momentum (EPS, ROE, revenue), price-volume confirmation, and macro filters. I also use…